dc.contributor.author | Tzellos, Thrasyvoulos | |
dc.contributor.author | Yang, H | |
dc.contributor.author | Mu, F | |
dc.contributor.author | Calimlim, B | |
dc.contributor.author | Signorovitch, J | |
dc.date.accessioned | 2022-06-08T11:48:40Z | |
dc.date.available | 2022-06-08T11:48:40Z | |
dc.date.issued | 2018-08-18 | |
dc.description.abstract | Background Hidradenitis suppurativa (HS), a chronic cutaneous disease, can negatively affect work life.
Objectives This retrospective cohort study evaluates the indirect burden among
employed patients with HS in the U.S.A.<p>
<p>Methods Newly diagnosed and general patients with HS, who were employees
(age 18–64 years) from a large claims database (Q1 1999 to Q1 2015), were
matched 1 : 5 to controls. Income growth and risk of leaving the workforce
were assessed among the newly diagnosed HS and control cohorts in the 5-year
study period. Income, work loss days and indirect costs (absenteeism and disability) were assessed among the general HS and control cohorts in the 1-year study
period.
<p>Results Newly diagnosed (n = 1003, mean age 39 5 years, 66 3% female) and
general patients with HS (n = 1204, mean age 39 9 years, 69 1% female) were
matched to 5015 and 6020 controls, respectively. Newly diagnosed patients with
HS had significantly slower income growth ($324 per year) and higher risk of
leaving the workforce (adjusted hazard ratio 1 65, 95% confidence interval 1 45–
1 88) compared with controls (all P < 0 05). General patients with HS had more
total days of work loss (18 4 vs. 7 7), higher annual total indirect costs ($2925
vs. $1483) and lower annual income ($54 925 vs. $62 357) than controls (all P
< 0 001).
<p>Conclusions Patients with newly diagnosed HS and general patients with HS experienced a greater indirect burden than matched controls. | en_US |
dc.identifier.citation | Tzellos T, Yang H, Mu, Calimlim, Signorovitch. Impact of hidradenitis suppurativa on work loss, indirect costs and income. British Journal of Dermatology (2019) 181, pp147–154 | en_US |
dc.identifier.cristinID | FRIDAID 1637782 | |
dc.identifier.doi | 10.1111/bjd.17101 | |
dc.identifier.issn | 0007-0963 | |
dc.identifier.issn | 1365-2133 | |
dc.identifier.uri | https://hdl.handle.net/10037/25401 | |
dc.language.iso | eng | en_US |
dc.publisher | Wiley | en_US |
dc.relation.journal | British Journal of Dermatology | |
dc.rights.accessRights | openAccess | en_US |
dc.rights.holder | Copyright 2018 The Author(s) | en_US |
dc.title | Impact of hidradenitis suppurativa on work loss, indirect costs and income | en_US |
dc.type.version | publishedVersion | en_US |
dc.type | Journal article | en_US |
dc.type | Tidsskriftartikkel | en_US |
dc.type | Peer reviewed | en_US |